Total Payments
$78,002
2024 Payments
$1,578
Companies
43
Transactions
792
Medicare Patients
719
Medicare Billing
$113,046
Payment Breakdown by Category
Consulting$34,515 (44.2%)
Other$20,625 (26.4%)
Food & Beverage$18,385 (23.6%)
Travel$4,222 (5.4%)
Education$254.57 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $34,515 | 10 | 44.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,875 | 10 | 25.5% |
| Food and Beverage | $18,385 | 740 | 23.6% |
| Travel and Lodging | $4,222 | 26 | 5.4% |
| Honoraria | $750.00 | 1 | 1.0% |
| Education | $254.57 | 5 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $49,600 | 196 | $0 (2024) |
| Gilead Sciences, Inc. | $18,395 | 242 | $0 (2024) |
| Theratechnologies Inc. | $3,665 | 15 | $0 (2022) |
| Merck Sharp & Dohme LLC | $1,248 | 74 | $0 (2024) |
| Allergan, Inc. | $745.06 | 56 | $0 (2020) |
| Janssen Scientific Affairs, LLC | $690.35 | 12 | $0 (2023) |
| Janssen Biotech, Inc. | $639.63 | 42 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $589.62 | 33 | $0 (2020) |
| AbbVie Inc. | $359.35 | 13 | $0 (2023) |
| Janssen Products, LP | $318.83 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,578 | 43 | Gilead Sciences, Inc. ($931.66) |
| 2023 | $2,068 | 61 | Gilead Sciences, Inc. ($1,145) |
| 2022 | $18,449 | 89 | ViiV Healthcare Company ($11,009) |
| 2021 | $15,283 | 65 | ViiV Healthcare Company ($14,173) |
| 2020 | $4,219 | 80 | ViiV Healthcare Company ($3,179) |
| 2019 | $9,984 | 156 | ViiV Healthcare Company ($6,908) |
| 2018 | $11,094 | 143 | ViiV Healthcare Company ($7,241) |
| 2017 | $15,327 | 155 | Gilead Sciences Inc ($7,777) |
All Payment Transactions
792 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: HIV | ||||||
| 11/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.55 | General |
| 11/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $128.54 | General |
| 11/19/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $29.84 | General |
| Category: HIV | ||||||
| 10/22/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $123.41 | General |
| Category: HIV | ||||||
| 10/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.05 | General |
| 10/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $92.78 | General |
| 10/02/2024 | Merck Sharp & Dohme LLC | DELSTRIGO (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/02/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: HIV | ||||||
| 09/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $21.51 | General |
| 09/10/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $24.10 | General |
| Category: HIV | ||||||
| 09/10/2024 | Boston Scientific Corporation | Varithena Administration Pack (Device) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Varithena_PI | ||||||
| 08/27/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.77 | General |
| 08/07/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: HIV | ||||||
| 07/10/2024 | Merck Sharp & Dohme LLC | DELSTRIGO (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/20/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.33 | General |
| 06/19/2024 | ViiV Healthcare Company | DOVATO (Drug), CABENUVA, APRETUDE | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: HIV | ||||||
| 06/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.45 | General |
| 05/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.87 | General |
| 05/21/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: HIV | ||||||
| 05/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $83.39 | General |
| 05/14/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $123.12 | General |
| Category: HIV | ||||||
| 05/08/2024 | Merck Sharp & Dohme LLC | DELSTRIGO (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $24.88 | General |
| 04/01/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 81 | 148 | $32,385 | $15,276 |
| 2022 | 3 | 97 | 188 | $37,035 | $16,909 |
| 2021 | 4 | 114 | 222 | $47,005 | $24,873 |
| 2020 | 11 | 427 | 778 | $149,091 | $55,988 |
Total Patients
719
Total Services
1,336
Medicare Billing
$113,046
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 43 | 96 | $24,000 | $11,525 | 48.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 25 | 33 | $6,105 | $2,668 | 43.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 19 | $2,280 | $1,082 | 47.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 43 | 97 | $24,250 | $11,472 | 47.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 61 | $11,285 | $5,059 | 44.8% |
| 90471 | Administration of vaccine | Office | 2022 | 20 | 30 | $1,500 | $377.65 | 25.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 37 | 130 | $34,621 | $18,482 | 53.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 36 | 41 | $7,529 | $4,007 | 53.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 34 | $4,155 | $2,146 | 51.6% |
| 90471 | Administration of 1 vaccine | Office | 2021 | 13 | 17 | $700.00 | $238.34 | 34.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 39 | 173 | $51,454 | $19,901 | 38.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 102 | 260 | $57,361 | $19,765 | 34.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 54 | 54 | $12,982 | $6,398 | 49.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 84 | 137 | $20,492 | $6,223 | 30.4% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 12 | 12 | $1,850 | $1,405 | 75.9% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 39 | 39 | $1,484 | $728.46 | 49.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 38 | 38 | $1,198 | $651.32 | 54.4% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 11 | 11 | $688.71 | $375.43 | 54.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 18 | 18 | $718.38 | $306.14 | 42.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 14 | 15 | $524.10 | $188.60 | 36.0% |
| 81003 | Automated urinalysis test | Office | 2020 | 16 | 21 | $337.89 | $46.75 | 13.8% |
About Dr. Mia Scott, DO
Dr. Mia Scott, DO is a Family Medicine healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1215019724.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mia Scott, DO has received a total of $78,002 in payments from pharmaceutical and medical device companies, with $1,578 received in 2024. These payments were reported across 792 transactions from 43 companies. The most common payment nature is "Consulting Fee" ($34,515).
As a Medicare-enrolled provider, Scott has provided services to 719 Medicare beneficiaries, totaling 1,336 services with total Medicare billing of $113,046. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Denver, CO
- Active Since 10/20/2006
- Last Updated 09/01/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215019724
Products in Payments
- CABENUVA (Biological) $12,593
- DOVATO (Drug) $9,150
- Truvada (Drug) $6,656
- TROGARZO (Drug) $949.01
- PREZCOBIX (Drug) $881.81
- APRETUDE (Biological) $616.97
- TRIUMEQ (Drug) $579.32
- Epclusa (Drug) $444.13
- SYMTUZA (Drug) $368.86
- PIFELTRO (Drug) $361.92
- FARXIGA (Drug) $344.68
- RUKOBIA (Drug) $318.61
- Symtuza (Drug) $300.10
- Descovy (Drug) $279.46
- ISENTRESS (Drug) $261.62
- JULUCA (Drug) $255.26
- VRAYLAR (Drug) $253.64
- Vascepa (Drug) $222.28
- EGRIFTA (Drug) $216.17
- DELSTRIGO (Drug) $203.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Denver
Dr. Ethan Lazarus, M.d, M.D
Family Medicine — Payments: $534,416
Family Medicine $534,416
Mark Deutchman, Md, MD
Family Medicine — Payments: $328,050
Family Medicine $328,050
Dr. Flory Kreutter, Md, MD
Family Medicine — Payments: $29,207
Family Medicine $29,207
Gerald Ahigian, M.d, M.D
Family Medicine — Payments: $18,168
Family Medicine $18,168
Susane Habashi-Ahigian, M.d, M.D
Family Medicine — Payments: $17,080
Family Medicine $17,080
Dr. Khoi Nguyen, D.o, D.O
Family Medicine — Payments: $14,000
Family Medicine $14,000